| |
Unique cases (n = 37)
|
Cases with insufficient reportinga(n = 9)
|
|---|
|
Age at HSTCL diagnosis, years
|
n = 36
|
n = 0
|
|
Mean
|
30
|
-
|
|
Median
|
26
|
-
|
|
Range
|
12 to 79
|
-
|
|
Disease duration, years
|
n = 16
|
n = 0
|
|
Mean
|
10
|
-
|
|
Median
|
6
|
-
|
|
Range
|
4 to 35
|
-
|
|
Sex, n (%)
|
n = 36
|
n = 6
|
|
Female
|
5 (14%)
|
1 (17%)
|
|
Survival, n (%)
|
n = 26
|
n = 4
|
|
Died
|
24 (92%)
|
4 (100%)
|
|
Survived
|
2 (8%)
|
0 (0%)
|
|
Physical examination and laboratory abnormalities at time of HSTCL diagnosis, n (%)
|
n = 19
|
n = 1
|
|
Hepatosplenomegaly or splenomegaly
|
19 (100%)
|
1 (100%)
|
|
Fever
|
9 (47%)
|
-
|
|
Cytopenia of any type
|
11 (58%)
|
-
|
|
Altered liver enzymes and/or LDH
|
5 (26%)
|
-
|
-
aInsufficient reporting on demographic information prevented us from identifying if the cases were unique. With each patient characteristic heading, the adjacent ‘n = x’ cells indicate the number of cases that reported on that particular demographic. The percentages calculated for sex, survival, and physical examination/laboratory abnormalities use this ‘n’ as the denominator. HSTCL, hepatosplenic T-cell lymphoma, LDH, lactate dehydrogenase.
